Yifeng Pharmacy (603939) — Cash Flow Quality Index
Yifeng Pharmacy (603939) has a Cash Flow Quality Index of 1.86x as of September 2025. Operating cash flow of CN¥641.93 Million exceeds net income of CN¥344.51 Million, indicating high earnings quality where cash backs reported profits. Explore long-term investment intensity of Yifeng Pharmacy to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Yifeng Pharmacy Cash Flow Quality Index (2011–2024)
Historical Cash Flow Quality Index for Yifeng Pharmacy across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is Yifeng Pharmacy's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Yifeng Pharmacy (2011–2024)
Year-by-year earnings quality comparison for Yifeng Pharmacy. For live market cap and the full company financial profile, see Yifeng Pharmacy stock valuation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.55x | CN¥4.22 Billion | CN¥1.65 Billion | ▼ -22.7% |
| 2023 | 3.30x | CN¥4.66 Billion | CN¥1.41 Billion | ▲ +20.2% |
| 2022 | 2.75x | CN¥3.92 Billion | CN¥1.43 Billion | ▲ +26.6% |
| 2021 | 2.17x | CN¥2.15 Billion | CN¥990.75 Million | ▲ +40.8% |
| 2020 | 1.54x | CN¥1.34 Billion | CN¥866.85 Million | ▼ -2.6% |
| 2019 | 1.58x | CN¥963.23 Million | CN¥608.88 Million | ▲ +36.8% |
| 2018 | 1.16x | CN¥510.71 Million | CN¥441.57 Million | ▲ +15.8% |
| 2017 | 1.00x | CN¥317.20 Million | CN¥317.47 Million | ▲ +62.7% |
| 2016 | 0.61x | CN¥139.94 Million | CN¥227.92 Million | ▼ -39.7% |
| 2015 | 1.02x | CN¥181.52 Million | CN¥178.24 Million | ▼ -31.7% |
| 2014 | 1.49x | CN¥212.35 Million | CN¥142.40 Million | ▼ -4.5% |
| 2013 | 1.56x | CN¥156.71 Million | CN¥100.38 Million | ▲ +34.5% |
| 2012 | 1.16x | CN¥80.73 Million | CN¥69.54 Million | ▼ -47.3% |
| 2011 | 2.20x | CN¥122.99 Million | CN¥55.88 Million | — |